Impact of Race on Clinical Outcomes in IBD Patients on Anti-TNF Monotherapy and Anti-TNF Combination Therapy With Immunomodulators: A Propensity-Matched Cohort Study

被引：0
|
作者：
Nawaz, Ahmad [1 ]
Almasaid, Sharifeh [1 ]
Shah, Ayushi [1 ]
Hussain, Azhar [1 ]
Chaar, Abdelkader [1 ]
Patel, Shanti [2 ]
Khalid, Fatima [3 ]
Hayat, Umar [4 ]
Singh, Kelita [1 ]
Aswath, Ganesh [1 ]
Khan, Hafiz Muzaffar Akbar [1 ]
机构：
[1] SUNY Syracuse, Upstate Med Univ, Syracuse, NY USA
[2] Yale New Haven Hosp, New Haven, CT USA
[3] Fatima Mem Hosp, Lahore, Punjab, Pakistan
[4] Geisinger Wyoming Valley Med Ctr, Wilkes Barre, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001035020.13797.dd
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1413
引用
收藏
页码：S1011 / S1012
页数：2
相关论文
共 50 条
  • [21] Letter: immunogenicity of anti-TNF in elderly IBD patients
    Paul, Stephane
    Roblin, Xavier
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (03) : 336 - 336
  • [22] Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD
    Rafael Denadai
    Fábio V. Teixeira
    Rogério Saad-Hossne
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 744 - 744
  • [23] Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD
    Denadai, Rafael
    Teixeira, Fabio V.
    Saad-Hossnethe, Rogerio
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (12) : 744 - 744
  • [24] Mitigating tuberculosis reactivation risk in IBD patients on anti-TNF therapy
    Kumar, Peeyush
    Kedia, Saurabh
    Ahuja, Vineet
    ARAB JOURNAL OF GASTROENTEROLOGY, 2024, 25 (04) : 455 - 456
  • [25] Major Adverse Cardiovascular Events in Patients With IBD Taking Anti-TNF vs JAK Inhibitors: A Propensity Matched Cohort Analysis
    Alsakarneh, Saqr
    Madi, Mahmoud
    Jaber, Fouad
    Farraye, Francis A.
    Faye, Adam S.
    Caldera, Freddy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) : S733 - S733
  • [26] CLINICAL EFFICACY TO A SECOND ANTI-TNF THERAPY IS ASSOCIATED WITH THE DEVELOPMENT OF ANTIBODIES AGAINST THE FIRST ANTI-TNF THERAPY IN PATIENTS WITH SPONDYLOARTRHITIS
    Garcia Carazo, S.
    Plasencia, C.
    Pascual Salcedo, D.
    Bonilla Hernan, G.
    Lojo, L.
    Villalba, A.
    Nuno, L.
    del Olmo, L.
    Gil Barato, S.
    Alcocer Amores, P.
    Arribas, F.
    Perez, E.
    Martin Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 250 - 251
  • [27] IBD Antibodies to anti-TNF therapy-consequences for IBD management
    van Deen, Welmoed K.
    Hommes, Daniel W.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (08) : 446 - 448
  • [28] ANTI-TNF IN COMBINATION WITH LOW DOSE METHOTREXATE OUTPERFORMS ANTI-TNF MONOTHERAPY IN PATIENTS WITH PEDIATRIC CROHN'S DISEASE INITIATING ADALIMUMAB BUT NOT INFLIXIMAB
    Kappelman, Michael
    Wohl, David A.
    Herfarth, Hans
    Firestine, Ann M.
    Adler, Jeremy
    Steiner, Steven J.
    Colletti, Richard B.
    Park, K. T.
    Grossman, Andrew B.
    Ivanova, Anastasia
    Galanko, Joseph
    Osaba, Lourdes
    Chun, Kelly Y.
    Weinberger, Morris
    Margolis, Peter
    Saeed, Shehzad
    Bousvaros, Athos
    GASTROENTEROLOGY, 2023, 164 (06) : S168 - S169
  • [29] OUTCOMES OF PREGNANCY IN IBD PATIETNS TREATED WITH VEDOLIZUMAB, ANTI-TNF OR CONVENTIONAL THERAPY
    Moens, Annick
    Van der Woude, Christien Janneke
    Julsgaard, Mette
    Sebastian, Shaji
    Arebi, Naila
    Alzinaty, Mohannad
    Humblet, Evelien
    Kok, Klaartje
    Sheridan, Juliette
    Gilletta, Cyrielle
    Nancey, Stephane
    Rahier, Jean-Francois
    Bossuyt, Peter
    Cremer, Anneline
    Dewit, Sophie
    Eriksson, Carl
    Hoentjen, Frank
    Krause, Thomas
    Louis, Edouard
    Macken, Elisabeth
    Milenkovic, Zoran
    Nijs, Jochen
    Posen, Annelies
    Van Hootegem, Anneleen
    Van Moerkercke, Wouter
    Vermeire, Severine
    Shitrit, Ariella Bar-Gil
    Ferrante, Marc
    GASTROENTEROLOGY, 2019, 156 (06) : S633 - S633
  • [30] The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
    Chamaida Plasencia
    Dora Pascual-Salcedo
    Sara García-Carazo
    Leticia Lojo
    Laura Nuño
    Alejandro Villalba
    Diana Peiteado
    Florencia Arribas
    Jesus Díez
    Maria Teresa López-Casla
    Emilio Martín-Mola
    Alejandro Balsa
    Arthritis Research & Therapy, 15
12345